These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27331595)

  • 1. Participant Experiences and Views of Odor and PrePex Device Removal Pain in a VMMC Pilot Study in Botswana.
    Musiige AM; Ashengo TA; Stolarsky G; Dialwa RT; Manda R; Ntsuape CO; Mafeni J; Busang L; Curran K; Motlhoiwa K; Mwangemi FJ; Lukobo-Durrell M; Glenshaw MT
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S73-7. PubMed ID: 27331595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Acceptability of the PrePex Device When Used in Routine Male Circumcision Service Delivery During Active Surveillance in Zimbabwe.
    Mavhu W; Hatzold K; Ncube G; Xaba S; Madidi N; Keatinge J; Dhodho E; Samkange CA; Tshimanga M; Mangwiro T; Mugurungi O; Njeuhmeli E; Cowan FM
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S63-8. PubMed ID: 27331593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
    Feldblum P; Martinson N; Bvulani B; Taruberekera N; Mahomed M; Chintu N; Milovanovic M; Hart C; Billy S; Necochea E; Samona A; Mhazo M; Bossemeyer D; Lai JJ; Lebinai L; Ashengo TA; Macaringue L; Veena V; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S43-8. PubMed ID: 27331589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Odor Level when Using PrePex for HIV Prevention: A Prospective, Randomized, Open Label, Blinded Assessor Trial to Improve Uptake of Male Circumcision.
    Mutabazi V; Bitega JP; Ngeruka LM; Karema C; Binagwaho A
    PLoS One; 2015; 10(5):e0126664. PubMed ID: 26023772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrePex circumcision surveillance: Adverse events and analgesia for device removal.
    Lebina L; Milovanovic M; Otwombe K; Abraham P; Manentsa M; Nzenze S; Martinson N
    PLoS One; 2018; 13(3):e0194271. PubMed ID: 29579082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piloting PrePex for Adult and Adolescent Male Circumcision in South Africa--Pain Is an Issue.
    Lebina L; Taruberekera N; Milovanovic M; Hatzold K; Mhazo M; Nhlapo C; Tshabangu N; Manentsa M; Kazangarare V; Makola M; Billy S; Martinson N
    PLoS One; 2015; 10(9):e0138755. PubMed ID: 26405786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the PrePex device an alternative for surgical male circumcision in adolescents ages 13-17 years? Findings from routine service delivery during active surveillance in Zimbabwe.
    Mavhu W; Hatzold K; Madidi N; Maponga B; Dhlamini R; Munjoma M; Xaba S; Ncube G; Mugurungi O; Cowan FM
    PLoS One; 2019; 14(3):e0213399. PubMed ID: 30856228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Profile of PrePex Male Circumcision Device and Client Satisfaction With Adolescent Males Aged 13-17 Years in Zimbabwe.
    Tshimanga M; Hatzold K; Mugurungi O; Mangwiro T; Ncube G; Xaba S; Chatikobo P; Gundidza P; Samkange C; Dhlamini R; Murwira M; Gwinji G
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S36-42. PubMed ID: 27331588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, effectiveness and acceptability of the PrePex device for adult male circumcision in Kenya.
    Feldblum PJ; Odoyo-June E; Obiero W; Bailey RC; Combes S; Hart C; Jou Lai J; Fischer S; Cherutich P
    PLoS One; 2014; 9(5):e95357. PubMed ID: 24788898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention.
    Mutabazi V; Kaplan SA; Rwamasirabo E; Bitega JP; Ngeruka ML; Savio D; Karema C; Binagwaho A
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):315-22. PubMed ID: 23466648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and acceptance of the PrePex device for non-surgical adult male circumcision in Rakai, Uganda. A non-randomized observational study.
    Kigozi G; Musoke R; Watya S; Kighoma N; Nkale J; Nakafeero M; Namuguzi D; Serwada D; Nalugoda F; Sewankambo N; Wawer MJ; Gray RH
    PLoS One; 2014; 9(8):e100008. PubMed ID: 25144194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, Feasibility, and Acceptability of the PrePex Device for Adult Male Circumcision in Malawi.
    Kohler PK; Tippett Barr BA; Kangʼombe A; Hofstee C; Kilembe F; Galagan S; Chilongozi D; Namate D; Machaya M; Kabwere K; Mwale M; Msunguma W; Reed J; Chimbwandira F
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S49-55. PubMed ID: 27331590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events profile of PrePex a non-surgical device for adult male circumcision in a Ugandan urban setting.
    Galukande M; Duffy K; Bitega JP; Rackara S; Bbaale DS; Nakaggwa F; Nagaddya T; Wooding N; Dea M; Coutinho A
    PLoS One; 2014; 9(1):e86631. PubMed ID: 24489754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe.
    Bochner AF; Feldacker C; Makunike B; Holec M; Murenje V; Stepaniak A; Xaba S; Balachandra S; Tshimanga M; Chitimbire V; Barnhart S
    J Int AIDS Soc; 2017 Feb; 19(1):21394. PubMed ID: 28362066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions of the PrePex Device Among Men Who Received or Refused PrePex Circumcision and People Accompanying Them.
    Milovanovic M; Taruberekera N; Martinson N; Lebina L
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S78-82. PubMed ID: 27331596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and Satisfaction Associated With the Introduction of the PrePex Circumcision Device in Maputo, Mozambique.
    Cummings B; Necochea E; Ferreira T; Soares B; Mahomed M; Muquingue H; Nhambi L; Bossemeyer D; Ashengo TA
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S56-62. PubMed ID: 27331592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase II Randomized Controlled Trial Comparing Safety, Procedure Time, and Cost of the PrePex™ Device to Forceps Guided Surgical Circumcision in Zimbabwe.
    Tshimanga M; Mangwiro T; Mugurungi O; Xaba S; Murwira M; Kasprzyk D; Montaño DE; Nyamukapa D; Tambashe B; Chatikobo P; Gundidza P; Gwinji G
    PLoS One; 2016; 11(5):e0156220. PubMed ID: 27227679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected Complications Following Adult Medical Male Circumcision Using the PrePex Device.
    Odoyo-June E; Feldblum PJ; Fischer S; Bailey RC; Obiero W; Hart C; Veena V; Combes S; Cherutich P
    Urol Int; 2016; 96(2):188-93. PubMed ID: 26684654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Cost Analysis of Surgical and PrePex Device Male Circumcision in Zimbabwe and Mozambique.
    Schutte C; Tshimanga M; Mugurungi O; Come I; Necochea E; Mahomed M; Xaba S; Bossemeyer D; Ferreira T; Macaringue L; Chatikobo P; Gundididza P; Hatzold K
    J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S96-S100. PubMed ID: 27331599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary Medical Male Circumcision to Prevent HIV in Tanah Papua, Indonesia: Field Trial to Assess Acceptability and Feasibility.
    Ansari MR; Lazuardi E; Wignall FS; Karma C; Sumule SA; Tarmizi SN; Magnani R
    Curr HIV Res; 2017 Nov; 15(5):361-371. PubMed ID: 28990535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.